Acknowledgments
We would like to thank Kerry Hansen, RN, for assistance with data abstraction.
Disclosure
Lisa M Baumann Kreuziger and Tracy L Prosen have no interests which might be perceived as posing a conflict or bias. Mark T Reding began serving as an advisory board member for GTC Biotherapeutics after the above cases were managed. Funding for Lisa Baumann Kreuziger’s time to complete this work was supported by a NIH T32 training grant (5T32HL00706).
Disclosure
The authors report no conflicts of interest in this communication.